|
|
|
The new understanding of multiple myeloma has evolved from theory to practical clinical application. The initial successes promise to become very important for cancer patient care. There are many questions that will need evaluation, and the professional, patient and lay community is looking forward to these developments. We wish great success to this meeting, organized in collaboration with a great faculty and our two centers.
J. San Miguel and J.L. Harousseau
|
|
| |
|
COURSE OBJECTIVE
This course will provide haematologists, oncologists and others involved in the treatment of multiple myeloma with a background to understand the basic science and the clinical achievements in multiple myeloma therapy.
This is intended to be a practice oriented course, helping the clinician in decision making processes. Participants will have an opportunity to discuss patient case studies and interact with experts as well as receive updates on the latest data and advances in this field.
|
|
| |
|
| Course Co-ordinator: M. Aapro |
|
 |
|
|
|
| Chairs: Jesus San Miguel and Jean-Luc Harousseau |
|
 |
|
| Jesus San Miguel |
|
|
|
 |
|
| Jean-Luc Harousseau |
|
|
|
|
|
